Clinical Trials Directory

Trials / Completed

CompletedNCT04647747

Silent Hypoxia and Awake Proning in COVID-19 Patients

Silent Hypoxia and Awake Proning in COVID-19 Patients: Home Monitoring and Self-Reporting

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Ostfold Hospital Trust · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The Investigators want to examine patients infected with SARS-CoV-2 for the phenomenon "Silent Hypoxia", which is clinically significant hypoxia without corresponding degree of dyspnea. The patient population is infected individuals without any serious symptoms and is at home. The participants will be equipped with a pulse oximeter and a PEF-measurement device. Four times daily the participants will register saturation, degree of dyspnea and PEF. If the participants experience desaturation or increasing dyspnea, physiotherapy is to be performed, and if that doesn't relieve symptoms or increase oxygen saturation, the hospital should be contacted for admission. The first part of this study is a feasibility study, and if found feasible, the investigators will expand the study to more participants.

Conditions

Interventions

TypeNameDescription
OTHERSelf measurement with pulse oximeterParticipant will measure peripheral saturation at home, conduct physiotherapy if desaturation occurs, and contact hospital if desatuation persists

Timeline

Start date
2020-11-30
Primary completion
2021-03-30
Completion
2021-03-30
First posted
2020-12-01
Last updated
2024-03-18

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT04647747. Inclusion in this directory is not an endorsement.